Skip navigation

Varig finansiering av IMPRESS-legemidler

  • Report number: 2025-50
  • Title: Varig finansiering av IMPRESS-legemidler
  • Client: CONNECT - Norwegian Cancer Precision Medicine
  • Published: November 25
  • Link: PDF
See all publications
Newest articles